Atezolizumab and Recombinant Human Hyaluronidase Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Atezolizumab + rHuPH20, Atezolizumab and Hyaluronidase, Atezolizumab and Hyaluronidase-tqjs, Atezolizumab and Recombinant Human Hyaluronidase-tqjs, Atezolizumab with rHuPH20 +6 more

Pipeline

Phase 3: 1

Top Sponsors

National Cancer Institute (NCI)1

Indications

Lung Non-Small Cell Carcinoma1
Lung Cancer1
Cancer1

Coeur d'Alene, Idaho1 trial

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

Kootenai Health - Coeur d'Alene

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.